BCAX - Bicara Therapeutics Inc. Common Stock

https://www.bicara.com

Hold Momentum: Bearish

Recent News

Bicara Therapeutics Shares Sink Over 43% On Friday - Bicara Therapeutics ( NASDAQ:BCAX )

Benzinga • 3 months, 3 weeks ago • score: 0.17

Bicara shares plunged over 43% after interim trial data for ficerafusp alfa showed mixed results. Despite a 64% response rate in HPV-negative patients, investors reacted negatively to the lack of mature overall survival

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. The company is headquartered in Boston, Massachusetts.

52W High

$28.09

52W Low

$7.80

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

1.51

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

12.23%

Institutions (25–75% balanced)

93.88%

Shares Outstanding

54,563,000

Float

24,134,200

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-4.66

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.33%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.2679

0.3348

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025